Cannabis
Pure Extracts Ships Repeat Orders of Vape Cartridges and Edibles to Alberta
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis and hemp is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has shipped repeat orders of vape carts and edible gummies via its distribution partner, Abba Medix Corp., to Alberta Gaming, Liquor & Cannabis (AGLC), the sole wholesale distributor of non-medical cannabis in the province.
This shipment includes follow-on orders for 3 Pure Pulls SKUs of 1 gram THC full spectrum oil (FSO) vapes as well as follow-on orders for 2 Pure Chews SKUs of ultra-high potency CBD edible gummies. The Pure Pulls branded vape cartridges were filled with a selection of some of the Company’s 30+ proprietary cannabis FSO formulations including Super Lemon Haze, Grand Daddy Purple and GSC. The edibles were the Company’s unique Blue Raspberry flavour.
All the Company’s Pure Chews edible SKUs utilize a proprietary manufacturing system licensed from US based Taste-T, LLC, the manufacturer of the successful Fireball Cinnamon gummies, to produce and package branded gummies that come in unique blister packaging offering convenience and guaranteeing freshness.
Pure Extracts CEO, Ben Nikolaevsky, remarked, “We are pleased to see consistent demand for our branded products in Alberta. The repeat orders we have shipped to AGLC underscore the high-quality of our products and the reliability of our manufacturing processes.”
ON BEHALF OF THE BOARD
“Ben Nikolaevsky”
Ben Nikolaevsky
CEO and Director
About Pure Extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
Find out more at https://pureextractscorp.com/
Or contact:
Pure Extracts Investor Relations
Tel: +1 604 493 2052
[email protected]
The CSE has neither approved nor disapproved the contents of this press release.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis7 days ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care